MedTrace Logo

DD T2 Daily Disposable Registration Trial

NCT03305770 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 107

Last updated 2019-02-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the performance of the investigational verofilcon A contact lens compared to the commercially available delefilcon A contact lens, by assessing visual acuity as the primary variable.

Conditions

  • Myopia
  • Refractive Errors

Interventions

DEVICE

verofilcon A contact lenses

Daily disposable soft contact lenses

DEVICE

delefilcon A contact lenses

Daily disposable soft contact lenses

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Alcon, a Novartis Division · Alcon, a Novartis Division

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-12
Primary Completion
2018-02-21
Completion
2018-02-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03305770 on ClinicalTrials.gov